+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Characterization of the myricetin-human serum albumin complex by spectroscopic and molecular modeling approaches



Characterization of the myricetin-human serum albumin complex by spectroscopic and molecular modeling approaches



Biomacromolecules 8(7): 2182-2189



The interaction mechanism of flavonol myricetin (3,5,7,3',4',5'-hexahydroxyflavone) and human serum albumin (HSA) has been characterized by fluorescence, electronic absorption, and Fourier transform infrared (FT-IR) spectroscopic approaches and the molecular modeling method. The structural characteristics of myricetin and HSA were probed, and their binding affinities were determined under different pH conditions. The results showed that the binding abilities of the drug to protein decreased under lower pH conditions (pH 3.5 and 2.0) due to the alterations of the protein secondary and tertiary structures. The second derivative absorption spectra of myricetin after interacting with the protein showed that the drug existed as an anion form in the binding pocket. The fluorescence emission intensities of the normal and excited-state proton transfer (ESTP) tautomer of myricetin significantly enhanced in the presence of HSA with conspicuous shifts of the emission bands when excited with a wavelength of 370 nm, while the intensity ratios of the normal to ESTP tautomers rose rapidly with the increase of the HSA concentrations under different pH environments. This illustrated that the fluorescence emission of the normal tautomer (S1-S0, non-proton-transferred) predominated due to the interaction of drug and surrounding polar and ionic side chains of amino acid residues in the binding cavity. The similar spectroscopic properties of myricetin-HSA complex at pH 7.4 and 3.5 showed that the drug was located in subdomain IIA of the protein in the vicinity of the single Trp 214 because of the unfolding of the protein domain III in its F state. From the molecular modeling results, the drug-protein complex was stabilized by electrostatic force and hydrogen bonding with the amino acid residue in the binding pocket, which was consistent with the experimental results.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 015253103

Download citation: RISBibTeXText

PMID: 17559264

DOI: 10.1021/bm070319c


Related references

Characterization of the mangiferin-human serum albumin complex by spectroscopic and molecular modeling approaches. Journal of Pharmaceutical and Biomedical Analysis 49(3): 753-759, 2009

Exploring the site-selective binding of jatrorrhizine to human serum albumin: spectroscopic and molecular modeling approaches. Spectrochimica Acta. Part A, Molecular and Biomolecular Spectroscopy 117: 163-169, 2014

Spectroscopic and molecular modeling approaches to investigate the binding of proton pump inhibitors to human serum albumin. Journal of Biomolecular Structure and Dynamics 35(15): 3205-3220, 2016

Study of the enantioselective interaction of diclofop and human serum albumin by spectroscopic and molecular modeling approaches in vitro. Chirality 25(11): 719-725, 2014

Characterization of the interaction between nitrofurazone and human serum albumin by spectroscopic and molecular modeling methods. Molecular Biosystems 8(5): 1446-1451, 2012

Probing the binding interaction of human serum albumin with three bioactive constituents of Eriobotrta japonica leaves: Spectroscopic and molecular modeling approaches. Journal of Photochemistry and Photobiology. B, Biology 148: 268-276, 2016

Separate and simultaneous binding effects through a non-cooperative behavior between cyclophosphamide hydrochloride and fluoxymesterone upon interaction with human serum albumin: multi-spectroscopic and molecular modeling approaches. Spectrochimica Acta. Part A, Molecular and Biomolecular Spectroscopy 88: 177-191, 2012

Binding site identification of metformin to human serum albumin and glycated human serum albumin by spectroscopic and molecular modeling techniques: a comparison study. Journal of Biomolecular Structure and Dynamics 33(3): 513-533, 2016

Characterization of the baicalein-bovine serum albumin complex without or with Cu2+ or Fe3+ by spectroscopic approaches. European Journal of Medicinal Chemistry 46(2): 588-599, 2011

Characterization of the interaction between eupatorin and bovine serum albumin by spectroscopic and molecular modeling methods. International Journal of Molecular Sciences 14(7): 14185-14203, 2013

Molecular interactions of isoxazolcurcumin with human serum albumin: spectroscopic and molecular modeling studies. Biopolymers 91(2): 108-119, 2008

Molecular interaction of human serum albumin with paracetamol: spectroscopic and molecular modeling studies. International Journal of Biological Macromolecules 45(2): 129-134, 2009

Molecular interaction of PCB153 to human serum albumin: insights from spectroscopic and molecular modeling studies. Journal of Hazardous Materials 248-249: 313-321, 2013

Molecular interactions of benzophenone UV filters with human serum albumin revealed by spectroscopic techniques and molecular modeling. Journal of Hazardous Materials 263 Pt 2: 618-626, 2014

Interaction of virstatin with human serum albumin: spectroscopic analysis and molecular modeling. Plos One 7(5): E37468, 2012